These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4607700)

  • 1. CircRNAs in anticancer drug resistance: recent advances and future potential.
    Xu T; Wang M; Jiang L; Ma L; Wan L; Chen Q; Wei C; Wang Z
    Mol Cancer; 2020 Aug; 19(1):127. PubMed ID: 32799866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Program implementation gaps and ethical issues in the prevention of HIV infection among infants, children, and adolescents in sub-Saharan Africa.
    Sam-Agudu NA; Folayan MO; Haire BG
    Pediatr Res; 2020 Jan; 87(2):406-413. PubMed ID: 31663519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.
    Fallah F; Fallah M; Sajadi Nia RS
    Curr Urol; 2013 Jan; 6(3):160-4. PubMed ID: 24917736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma.
    Reeve JG; Wright KA; Twentyman PR
    Br J Cancer; 1983 Jun; 47(6):841-8. PubMed ID: 6860550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay.
    Ludwig R; Alberts DS
    Cancer Chemother Pharmacol; 1984; 12(3):142-5. PubMed ID: 6705131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.
    Ludwig R; Alberts DS; Miller TP; Salmon SE
    Cancer Chemother Pharmacol; 1984; 12(3):135-41. PubMed ID: 6705130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay.
    Matsushima Y; Kanzawa F; Hoshi A; Shimizu E; Nomori H; Sasaki Y; Saijo N
    Cancer Chemother Pharmacol; 1985; 14(2):104-7. PubMed ID: 3971474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.
    Kantarjian HM; Barlogie B; Keating MJ; Hall RR; Smith TL; McCredie KB; Freireich EJ
    J Clin Invest; 1985 Jul; 76(1):319-24. PubMed ID: 3860508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
    Roed H; Vindelov LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Cancer Chemother Pharmacol; 1987; 19(1):16-20. PubMed ID: 3815721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.
    Finlay GJ; Wilson WR; Baguley BC
    Br J Cancer; 1987 Dec; 56(6):755-62. PubMed ID: 3435703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective killing of transformed fibroblasts by combined treatment with cycloheximide and aphidicolin.
    Okuda A; Kimura G
    Jpn J Cancer Res; 1989 May; 80(5):452-8. PubMed ID: 2546909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
    Kim M; Woo KB; Perry S
    Ann Biomed Eng; 1977 Mar; 5(1):12-33. PubMed ID: 557938
    [No Abstract]   [Full Text] [Related]  

  • 13. Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.
    Duménil D; Sainteny F; Frindel E
    Cancer Chemother Pharmacol; 1979; 2(3):203-7. PubMed ID: 455576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some effects of chemotherapeutic drugs on bone marrow stem cells. I. The long-term effects of phase-specific drugs on mouse bone marrow stem cells.
    Duménil D; Sainteny F; Frindel E
    Cancer Chemother Pharmacol; 1979; 2(3):197-201. PubMed ID: 455575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 32P test and other methods in the diagnosis of intraocular tumors. (Thesis).
    Van Dijk RA
    Doc Ophthalmol; 1978 Oct; 46(1):1-132. PubMed ID: 365479
    [No Abstract]   [Full Text] [Related]  

  • 16. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1976 Mar; 33(3):320-8. PubMed ID: 57788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are cell kinetic data relevant for the design of tumour chemotherapy schedules?
    van Putten LM
    Cell Tissue Kinet; 1974 Sep; 7(5):493-504. PubMed ID: 4607700
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of cell kinetics in the development of drug combinations.
    Valeriote FA
    Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.